Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study.

Journal: Clinical & experimental metastasis
Published Date:

Abstract

Histopathological growth patterns (HGPs) are independent prognosticators for colorectal liver metastases (CRLM). Currently, HGPs are determined postoperatively. In this study, we evaluated radiomics for preoperative prediction of HGPs on computed tomography (CT), and its robustness to segmentation and acquisition variations. Patients with pure HGPs [i.e. 100% desmoplastic (dHGP) or 100% replacement (rHGP)] and a CT-scan who were surgically treated at the Erasmus MC between 2003-2015 were included retrospectively. Each lesion was segmented by three clinicians and a convolutional neural network (CNN). A prediction model was created using 564 radiomics features and a combination of machine learning approaches by training on the clinician's and testing on the unseen CNN segmentations. The intra-class correlation coefficient (ICC) was used to select features robust to segmentation variations; ComBat was used to harmonize for acquisition variations. Evaluation was performed through a 100 × random-split cross-validation. The study included 93 CRLM in 76 patients (48% dHGP; 52% rHGP). Despite substantial differences between the segmentations of the three clinicians and the CNN, the radiomics model had a mean area under the curve of 0.69. ICC-based feature selection or ComBat yielded no improvement. Concluding, the combination of a CNN for segmentation and radiomics for classification has potential for automatically distinguishing dHGPs from rHGP, and is robust to segmentation and acquisition variations. Pending further optimization, including extension to mixed HGPs, our model may serve as a preoperative addition to postoperative HGP assessment, enabling further exploitation of HGPs as a biomarker.

Authors

  • Martijn P A Starmans
    Biomedical Imaging Group Rotterdam, Departments of Radiology and Nuclear Medicine Medical Informatics, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.
  • Florian E Buisman
    Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Michel Renckens
    Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • François E J A Willemssen
    Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.
  • Sebastian R van der Voort
    Biomedical Imaging Group Rotterdam, Departments of Radiology and Nuclear Medicine Medical Informatics, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.
  • Bas Groot Koerkamp
    Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Dirk J Grünhagen
    Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Centre, University Medical Centre Rotterdam, the Netherlands.
  • Wiro J Niessen
    Biomedical Imaging Group Rotterdam, Departments of Medical Informatics and Radiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Peter B Vermeulen
    Translational Cancer Research Unit, Department of Oncological Research, Oncology Center, GZA Hospitals Campus Sint-Augustinus and University of Antwerp, Antwerp, Belgium.
  • Cornelis Verhoef
    Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Centre, University Medical Centre Rotterdam, the Netherlands.
  • Jacob J Visser
    Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Stefan Klein